American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm

PHASE3CompletedINTERVENTIONAL

Enrollment

629

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions

Atrial FibrillationAtrial Flutter

Interventions

DRUG

Dronedarone (SR33589)

oral administration

DRUG

placebo

oral administration

Trial Locations (5)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Buenos Aires

sanofi-aventis Australia administrative office, Macquarie Park

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Midrand